Ballentine Partners, LLC - ARCUTIS BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
Ballentine Partners, LLC ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$55,150
-42.7%
10,386
+2.8%
0.00%
-50.0%
Q2 2023$96,301
-14.1%
10,105
-0.9%
0.00%
-33.3%
Q1 2023$112,123
-44.2%
10,193
+38.2%
0.00%
-57.1%
Q2 2021$201,0007,3770.01%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,434,232$162,443,00013.84%
Bain Capital Life Sciences Investors, LLC 3,979,292$76,641,0007.44%
Pivotal bioVenture Partners Investment Advisor LLC 569,041$10,960,0005.19%
Logos Global Management LP 1,500,000$28,890,0003.75%
Omega Fund Management, LLC 623,836$12,015,0002.46%
Orbimed Advisors 6,073,850$116,982,0001.90%
MPM BioImpact LLC 258,500$4,979,0001.34%
1492 Capital Management LLC 75,192$1,448,0000.77%
SECTORAL ASSET MANAGEMENT INC 219,136$4,221,0000.75%
EcoR1 Capital, LLC 895,503$17,247,0000.54%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders